Embryonic Dopamine Cell Implants for Parkinson's Disease

Completed · Phase 3 · Has a placebo group

Conditions studied: Parkinson Disease

In brief

The purpose of this trial is to determine if patients who received embryonic dopamine cell implant surgery showed significantly greater improvement in their Parkinson's disease than a control group undergoing the placebo treatment, and to determine if the cell implant surgery was more effective in younger or older patients.

Key facts

Study ID
NCT00038116
Run by
University of Colorado, Denver
People needed
40
Starts
1995-05-01
Expected to finish
2009-08-01
Last updated by the study team
2013-02-05

Who can join

Age: 20 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.